Article
Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Breast cancer research : BCR - 17 Feb 2020
Yanes Tatiane, Young Mary-Anne, Meiser Bettina, James Paul A
Abstract excerpt
Polygenic factors are estimated to account for an additional 18% of the familial relative risk of breast cancer, with those at the highest level of polygenic risk distribution having a least a twofold increased risk of the disease. Polygenic testing promises to revolutionize health services by providing personalized risk assessments to women at high-risk of breast cancer and within population breast screening...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
